[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341378-105":59,"doc-detail-341378-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","risk-of-first-recurrence-after-treatment-in-a-population-based-cohort-of-young-women-with-breast-cancer","Risk of first recurrence after treatment in a population-based cohort of young women with breast cancer","","Breast cancer in women under 45 is rare yet frequently aggressive. This study analyzes loco-regional recurrences, distant recurrences, second breast cancers, and mortality in young patients to identify how age, tumor biology, and treatment influence outcomes. Using a population-based cohort of 776 women with non-metastatic breast cancer diagnosed from 1970–2012, multivariate Cox regression and competing-risk models estimate recurrence and death risks. Results show substantial early recurrence within five years and differential effects by age, stage, surgical factors, and hormone-related therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/risk-of-first-recurrence-after-treatment-in-a-population-based-cohort-of-young-women-with-breast-cancer/341378/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/risk-of-first-recurrence-after-treatment-in-a-population-based-cohort-of-young-women-with-breast-cancer/341378.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What outcomes are assessed in this study of young women with breast cancer?","Question",{"text":112,"@type":113},"The study evaluates loco-regional recurrences, distant recurrences, second breast cancers, and mortality.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How large is the cohort and what type of statistical methods are used?",{"text":117,"@type":113},"The cohort includes 776 women with non-metastatic breast cancer diagnosed at age ≤45 from 1970 to 2012. Multivariate Cox regression and competing risk models are used.",{"name":119,"@type":110,"acceptedAnswer":120},"When do most recurrences occur in the follow-up period?",{"text":121,"@type":113},"Most recurrences occur within the first five years after diagnosis, based on the study’s median follow-up.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341378,1790192953,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Breast Cancer Research and Treatment (2024) 206:615–623  \n[https://doi.org/10.1007/s10549-024-07338-2](https://doi.org/10.1007/s10549-024-07338-2)  \nRisk of first recurrence after treatment in a population‑based cohort of young women with breast cancer  \nRobin Schaffar1 · Simone Benhamou1,2 · Pierre O. Chappuis3,4 · Elisabetta Rapiti1  \nReceived: 21 December 2023 / Accepted: 10 April 2024 / Published online: 30 April 2024 © The Author(s) 2024  \nAbstract  \nPurpose Breast cancer (BC) in women under 45 is rare yet often aggressive. We aim to analyze loco-regional recurrences (LR), distant recurrences (DR), second breast cancers, and mortality in young BC patients.  \nMethods We enrolled 776 women with non-metastatic BC ≤45 years diagnosed from 1970 to 2012. Variables included age, family history, tumor stage/grade, and treatment. We used multivariate Cox regression and competing risk models.  \nResults Among the participants, 37.0% were diagnosed before the age of 40. Most had stage I or II, grade II, ER-and PRpositive, HER2-negative tumors. Over a median follow-up of 8.7 years, 10.1% experienced LR, 13.7% developed DR, and 10.8% died, primarily due to BC. The majority of recurrences occurred within the first five years. Older age (>40) significantly reduced the risk of LR and DR. Advanced disease stage, certain surgical strategies, and positive margins increased DR risk. In the cohort diagnosed between 2001 and 2012, recent diagnosis, triple-negative cancer, and hormonal therapy were associated with reduced LR risk. Breast-conserving surgery appeared to offer protective effects against DR. Conclusion This study highlights that BC in young women carries a significant risk of early recurrence, with age, tumor characteristics, and treatment modalities influencing outcomes. The findings emphasize the need for tailored treatment strategies for young BC patients, focusing on surgical precision and aggressive adjuvant therapy for high-risk cases. This research contributes valuable insights into managing BC in younger patients, aiding in improving long-term outcomes.  \nKeywords Breast cancer · Recurrences · Young women · Population-based studies  \nAbbreviations  \nBC Breast cancer  \nDR Distant recurrence  \nLR Loco-regional recurrence HR Hazard ratio  \nGCR Geneva cancer registry ER Estrogen receptor  \nPR Progesterone receptor BCS Breast-conserving surgery  \n* Robin Schaffar  \nrobin.schaffar@unige.ch  \n1 Geneva Cancer Registry, Global Health Institute, University of Geneva, Geneva, Switzerland  \n2 INSERM Unit 1018, Research Centre on Epidemiology and Population Health, Villejuif, Île-de-France, France  \n3 Division of Precision Oncology, Geneva University Hospitals, Geneva, Switzerland  \n4 Division of Genetic Medicine, Geneva University Hospitals, Geneva, Switzerland  \nBackground  \nA breast cancer (BC) diagnosis in young women is relatively rare. In 2020, the age-standardized incidence rate in Europe for women aged 45 and older was estimated at 228.6 per 100,000, compared to 20.1 per 100,000 for those 45 years or younger [1]. Breast cancer is the leading cause of cancer death among women under 45 [1] .  \nYoung women with BC typically present with larger, more aggressive, and advanced tumors, leading to shorter survival [2] . They have a higher risk of developing recurrences [3–5] . Particularly, loco-regional recurrences (LR) in this group have been linked to increased risks of distant metastasis and mortality [6] . BC subtypes also influence recurrence patterns. HER2-positive and triple-negative tumors, more common in younger women, are prone to local and distant recurrences (DR) [2, 7] .  \nThe risk of loco-regional and distant recurrences for young women with breast cancer has not been extensively investigated. Young patients with breast cancer usually represent a very small subset of eligible patients in randomized  \nclinical trials and observational study populations, the latter often reporting only on hospital-selected patients [8] . Few","cbCaiiiWKbqsYtLy","https://ap.wps.com/l/cbCaiiiWKbqsYtLy","pdf",499592,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Background\n## Incidence and risk in younger women\n## Recurrence patterns and subtype influence\n## Knowledge gaps\n## Rationale for competing risks\n# Methods\n## Cohort and case ascertainment","[{\"question\":\"What outcomes are assessed in this study of young women with breast cancer?\",\"answer\":\"The study evaluates loco-regional recurrences, distant recurrences, second breast cancers, and mortality.\"},{\"question\":\"How large is the cohort and what type of statistical methods are used?\",\"answer\":\"The cohort includes 776 women with non-metastatic breast cancer diagnosed at age ≤45 from 1970 to 2012. Multivariate Cox regression and competing risk models are used.\"},{\"question\":\"When do most recurrences occur in the follow-up period?\",\"answer\":\"Most recurrences occur within the first five years after diagnosis, based on the study’s median follow-up.\"}]","Risk of first recurrence after treatment in a population-based cohort of young women with breast cancer | PDF",1790041688,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e843e20dde744857ef6b1f47500b17a3.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f21c87b63036a5efdb9d7681a006fb64.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2f0e3d3b458303f17c63e59b33ff992.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23c886d58795a8dcf79bab3990c94988.webp",980,1301]